泽璟制药涨2.03%，成交额6852.92万元，主力资金净流入83.69万元

Core Viewpoint - Zai Jian Pharmaceutical has shown a significant stock price increase of 66.19% year-to-date, despite recent fluctuations in the market, indicating potential investor interest and market confidence in the company's growth prospects [1][2]. Group 1: Stock Performance - As of October 20, Zai Jian Pharmaceutical's stock price rose by 2.03% to 103.55 CNY per share, with a total market capitalization of 27.41 billion CNY [1]. - The stock has experienced a 2.22% increase over the last five trading days, a 7.96% decrease over the last 20 days, and a 22.42% decrease over the last 60 days [1]. Group 2: Financial Performance - For the first half of 2025, Zai Jian Pharmaceutical reported a revenue of 376 million CNY, reflecting a year-on-year growth of 56.07% [2]. - The company recorded a net profit attributable to shareholders of -72.80 million CNY, which is a 9.42% decrease compared to the previous period [2]. Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders increased to 8,795, a rise of 16.75%, while the average number of circulating shares per person decreased by 14.35% to 30,097 shares [2]. - Notable institutional shareholders include China Europe Medical Health Mixed A and others, with varying changes in their holdings [2].